Should we screen for coronary artery disease in asymptomatic chronic dialysis patients

Kidney International

Volumn 81, Issue 2, 2012, Pages 143-151

  De Vriese, An S ^a   Vandecasteele, Stefaan J ^a   Van Den Bergh, Barbara ^a   De Geeter, Frank W ^b  

^a Renal Unit   (Belgium)

^b NONE   (Belgium)

Author keywords

chronic dialysis; coronary angiography; coronary artery disease; dipyridamole; myocardial perfusion scintigraphy; screening

Indexed keywords

AMMNONIA N 13; BIOLOGICAL MARKER; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; RUBIDIUM 82; TROPONIN C; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIAGNOSTIC ACCURACY; DIALYSIS; ELECTRON BEAM TOMOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCINTIGRAPHY; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

EID: 84855199206     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.340     Document Type: Review

References (84)

1. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 1984; 25: 653-659. (Pubitemid 14079960)
2. Joki N, Hase H, Nakamura R, et al. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723. (Pubitemid 27170426)
3. Ohtake T, Kobayashi S, Moriya H, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148. (Pubitemid 41710326)
4. Charytan D, Kuntz RE, Mauri L, et al. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007; 49: 409-416.
5. Braun WE, Philips DF, Vidt DG. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984; 16: 603-607. (Pubitemid 14065531)
6. Koch M, Gradaus F, Schoebel FC, et al. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997; 12: 1187-1191. (Pubitemid 27230555)
7. Pidgeon GB, Lynn KL, Bailey RR, et al. Coronary angiography prior to renal transplantation. Nephrology 1995; 1: 59-64.
8. Chertow GM, Normand SL, Silva LR, et al. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis 2000; 35: 1044-1051. (Pubitemid 30354405)
9. Hemmelgarn BR, Southern D, Culleton BF, et al. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 1890-1895. (Pubitemid 39331897)
10. Manske C, Wang Y, Rector T, et al. Coronary revascularization in insulin dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998-1002.
11. Yasuda K, Kasuga H, Aoyama T, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332. (Pubitemid 44141924)
12. Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 2008; 19: 1643-1652.
13. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-3096. (Pubitemid 43113440)
14. Roberts MA, Hare DL, Macmillan N, et al. Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis. Ann Clin Biochem 2009; 46: 291-295.
15. Kumar N, Michelis MF, DeVita MV, et al. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 2011; 26: 665-670.
16. Jacobs LH, van de Kerkhof J, Mingels AM, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009; 46: 283-290.
17. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST segment depression in the diagnosis of coronary artery disease: a meta analysis. Circulation 1989; 80: 87-98. (Pubitemid 19178641)
18. Morrow CE, Schwartz JS, Sutherland DE, et al. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 1983; 146: 331-335. (Pubitemid 13001740)
19. Philipson JD, Carpenter BJ, Itzkcoff J, et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986; 81: 630-634. (Pubitemid 17178142)
20. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med 1991; 90: 563-570.
21. Schmidt A, Stefenelli T, Schuster E, et al. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37: 56-63. (Pubitemid 32055019)
22. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 2207-2214. (Pubitemid 41510099)
23. De Vriese AS, De Bacquer DA, Verbeke FH, et al. Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients. Kidney Int 2009; 76: 428-436.
24. Bart BA, Cen YY, Hendel RC, et al. Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol 2009; 16: 507-515.
25. Orie JE, Jabi H, Glass N, et al. Thallium 201 myocardial perfusion imaging and coronary arteriography in asymptomatic patients with end-stage renal disease secondary to juvenile onset diabetes mellitus. Transplant Proc 1986; 18: 1709-1710. (Pubitemid 17012321)
26. Boudreau RJ, Strony JT, duCret RP, et al. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 1990; 175: 103-105. (Pubitemid 20108548)
27. Marwick TH, Steinmuller DR, Underwood DA, et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990; 49: 100-103. (Pubitemid 20051594)
28. Vandenberg BF, Rossen JD, Grover-Mckay M, et al. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionucleotide methods. Transplantation 1996; 62: 1230-1235. (Pubitemid 27008545)
29. Dahan M, Viron BM, Faraggi M, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 1998; 54: 255-262. (Pubitemid 28288042)
30. Melissinos K, Delidou A, Grammenou S, et al. Study of the activity of lymphocyte adenosine deaminase in chronic renal failure. Clin Chim Acta 1983; 135: 9-12. (Pubitemid 14241232)
31. Marcen R, Lamas S, Orofino L, et al. Dipyridamole thallium-201 perfusion imaging for the study of ischemic heart disease in hemodialysis patients. Int J Artif Organs 1989; 12: 773-777. (Pubitemid 20075122)
32. Camp AD, Garvin PJ, Hoff J, et al. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990; 65: 1459-1463. (Pubitemid 20203263)
33. Iqbal A, Gibbons RJ, McGoon MD, et al. Noninvasive assessment of cardiac risk in insulin-dependent diabetic patients being evaluated for pancreatic transplantation using thallium-201 myocardial perfusion scintigraphy. Clin Transplant 1991; 5: 13-19.
34. Derfler K, Kletter K, Balcke P, et al. Predictive value of thallium-201- dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991; 36: 192-202.
35. Brown JH, Vites NP, Testa HJ, et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with endstage renal failure. Nephrol Dial Transplant 1993; 8: 433-437. (Pubitemid 23177870)
36. Mistry BM, Bastani B, Solomon H, et al. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 1998; 12: 130-135. (Pubitemid 128721314)
37. Lewis MS, Wilson RA, Walker K, et al. Factors in cardiac risk stratification of candidates for renal transplant. J Cardiovasc Risk 1999; 6: 251-255. (Pubitemid 29421887)
38. Fuster D, Magrina J, Ricart MJ, et al. Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy. Transpl Int 2000; 13: 327-332.
39. Feola M, Biggi A, Ribichini F, et al. Predicting cardiac events with TL201 dipyridamole myocardial scintigraphy in renal transplant recipients. J Nephrol 2002; 15: 48-53. (Pubitemid 34240097)
40. Patel AD, Abo-Auda WS, Davis JM, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol 2003; 92: 146-151. (Pubitemid 36835962)
41. De Lima JJ, Sabbaga E, Vieira ML, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42: 263-268. (Pubitemid 37093471)
42. Hase H, Joki N, Ishikawa H, et al. Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients. Ther Apher Dial 2006; 10: 321-327. (Pubitemid 44154761)
43. Caglar M, Mahmoudian B, Aytemir K, et al. Value of 99mTcmethoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nucl Med Commun 2006; 27: 61-69. (Pubitemid 44391841)
44. Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989; 64: 1017-1021. (Pubitemid 19266131)
45. Wong CF, Little MA, Vinjamuri S, et al. Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United Kingdom. Transplant Proc 2008; 40: 1324-1328. (Pubitemid 351853189)
46. Leonardi G, Tamagnone M, Ferro M, et al. Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases. Clin Transplant 2009; 23: 653-659.
47. Rabbat CG, Treleaven DJ, Russell D, et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14: 431-439. (Pubitemid 36150867)
48. Atkinson P, Chiu DY, Sharma R, et al. Predictive value of myocardial and coronary imaging in the long-term outcome of potential renal transplant recipients. Int J Cardiol 2011; 146: 191-196.
49. Venkataraman R, Hage FG, Dorfman T, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol 2008; 102: 1451-1456.
50. Welsh RC, Cockfield SM, Campbell P, et al. Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation. Transplantation 2011; 91: 213-218.
51. Herzog CA, Marwick TH, Pheley AM, et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33: 1080-1090. (Pubitemid 29252678)
52. Cortigiani L, Desideri A, Gigli G, et al. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. Int J Cardiol 2005; 103: 168-174. (Pubitemid 41096030)
53. Reis G, Marcovitz PA, Leichtman AB, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995; 75: 707-710.
54. Marwick TH, Lauer MS, Lobo A, et al. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 1998; 244: 155-161. (Pubitemid 28364801)
55. Rakhit DJ, Armstrong KA, Beller E, et al. Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. Am Heart J 2006; 152: 363-370. (Pubitemid 44093400)
56. Bergeron S, Hillis GS, Haugen EN, et al. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J 2007; 153: 385-391. (Pubitemid 46328755)
57. Ballal RS, Secknus MA, Mehta R, et al. Cardiac outcomes in coronary patients with submaximum dobumatine stress echocardiography. Am J Cardiol 1997; 80: 725-729. (Pubitemid 27413580)
58. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77: 175-179. (Pubitemid 26032606)
59. Brennan DC, Vedala G, Miller SB, et al. Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplant Proc 1997; 29: 233-234. (Pubitemid 27123388)
60. Bellasi A, Raggi P. Techniques and technologies to assess vascular calcification. Sem Dial 2007; 20: 129-133.
61. Matsuoka M, Iseki K, Tamashiro M, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-58. (Pubitemid 38508656)
62. Shantouf RS, Budoff MJ, Ahmadi N, et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010; 31: 419-425.
63. Sharples EJ, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis 2004; 43: 313-319. (Pubitemid 38146330)
64. Iio K, Nagasawa Y, Kimura T, et al. Assessment of coronary stenosis by a 16-slice MDCT scanner in asymptomatic diabetic patients starting dialysis therapy. Nephron Clin Pract 2008; 109: c72-c79.
65. Naya M, Di Carli MF. Myocardial perfusion PET/CT to evaluate known and suspected coronary artery disease. Q J Nucl Med Mol Imaging 2010; 54: 145-156.
66. Chong E, Poh KK, Liang S, et al. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol 2010; 23: 451-459.
67. James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010; 78: 803-809.
68. Weisbord SD, Bernardini J, Mor MK, et al. The effect of coronary angiography on residual renal function in patients on peritoneal dialysis. Clin Cardiol 2006; 29: 494-497. (Pubitemid 44713782)
69. Kumar N, Dahri L, Brown W, et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1907-1913.
70. Boden WE, O?Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516. (Pubitemid 46588415)
71. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007; 49: 1763-1769. (Pubitemid 46617863)
72. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634-2653.
73. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-224.
74. Patel RK, Mark PB, Johnston N, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant 2008; 8: 1673-1683.
75. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 3): S18-S20.
76. Danovitch GM, Hariharan S, Pirsch JD, et al. Clinical Practice Guidelines Committee of the American Society of Transplantation. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2002; 13: 528-535. (Pubitemid 34106297)
77. Kasiske BL, Cangro CB, Hariharan S, et al. American Society of Transplantation. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 2001; 1(Suppl 2): S3-S95.
78. Lentine KL, Hurst FP, Jindal RM, et al. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 2010; 55: 152-167.
79. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: e418-e499.
80. Joki N, Tanaka Y, Ishikawa H, et al. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease. Am J Nephrol 2009; 29: 420-425.
81. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41: 1329-1340. (Pubitemid 36438995)
82. Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension 2009; 53: 860-866.
83. Kaisar MO, Isbel NM, Johnson DW. Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Rev Recent Clin Trials 2008; 3: 79-88.
84. Kasiske BL, Israni AK, Snyder JJ, et al. Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST). Am J Kidney Dis 2011; 57: 908-916.